NCT00004009 2019-11-07R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous LeukemiaUniversity of Maryland, BaltimorePhase 1 Completed
NCT00005967 2013-02-11Tipifarnib in Treating Patients With Advanced Hematologic CancerNational Cancer Institute (NCI)Phase 1 Completed36 enrolled